Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Aránzazu Barquín"'
Autor:
Alfonso Yubero, Purificación Estévez, Aránzazu Barquín, Luisa Sánchez, Ana Santaballa, Bella Pajares, Piedad Reche, Carmen Salvador, Luis Manso, Raúl Márquez, Antonio González-Martín
Publikováno v:
Gynecologic Oncology Reports, Vol 48, Iss , Pp 101211- (2023)
The poly(ADP-ribose) polymerase inhibitor (PARPi) rucaparib is approved as maintenance therapy for patients with platinum-sensitive recurrent high-grade ovarian cancer (HGOC). The efficacy and safety of rucaparib after PARPi therapy are largely unkno
Externí odkaz:
https://doaj.org/article/cc16796a046e48fda32bbd7c694a6f16
Autor:
Alfonso Yubero, Aranzazu Barquín, Purificación Estévez, Bella Pajares, Luisa Sánchez, Piedad Reche, Jesús Alarcón, Julia Calzas, Lydia Gaba, José Fuentes, Ana Santaballa, Carmen Salvador, Luis Manso, Ana Herrero, Álvaro Taus, Raúl Márquez, Julia Madani, María Merino, Gloria Marquina, Victoria Casado, Manuel Constenla, María Gutiérrez, Alba Dosil, Antonio González-Martín
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background: Rucaparib is a poly(ADP-ribose) polymerase inhibitor approved in Europe as maintenance therapy for recurrent platinum-sensitive (Pt-S) ovarian cancer (OC). The Rucaparib Access Programme (RAP) was designed to provide early access
Externí odkaz:
https://doaj.org/article/535064772afa48388b62acdd5418de2a